Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

L Sala, M Bellin, CL Mummery - British journal of pharmacology, 2017 - Wiley Online Library
Cardiotoxicity is a severe side effect of drugs that induce structural or electrophysiological
changes in heart muscle cells. As a result, the heart undergoes failure and potentially lethal …

The hyperpolarization-activated cyclic nucleotide–gated channels: from biophysics to pharmacology of a unique family of ion channels

L Sartiani, G Mannaioni, A Masi, MN Romanelli… - Pharmacological …, 2017 - ASPET
Hyperpolarization-activated, cyclic nucleotide–gated (HCN) channels are important
members of the voltage-gated pore loop channels family. They show unique features: they …

A computational model of induced pluripotent stem‐cell derived cardiomyocytes incorporating experimental variability from multiple data sources

DC Kernik, S Morotti, HD Wu, P Garg… - The Journal of …, 2019 - Wiley Online Library
Key points Induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) capture
patient‐specific genotype–phenotype relationships, as well as cell‐to‐cell variability of …

Simultaneous electrical recording of cardiac electrophysiology and contraction on chip

F Qian, C Huang, YD Lin, AN Ivanovskaya, TJ O'Hara… - Lab on a Chip, 2017 - pubs.rsc.org
Prevailing commercialized cardiac platforms for in vitro drug development utilize planar
microelectrode arrays to map action potentials, or impedance sensing to record contraction …

Computational models of ventricular-and atrial-like human induced pluripotent stem cell derived cardiomyocytes

M Paci, J Hyttinen, K Aalto-Setälä, S Severi - Annals of biomedical …, 2013 - Springer
The clear importance of human induced pluripotent stem cell derived cardiomyocytes
(hiPSC-CMs) as an in-vitro model highlights the relevance of studying these cells and their …

[HTML][HTML] Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities

M Paci, RP Pölönen, D Cori, K Penttinen… - Frontiers in …, 2018 - frontiersin.org
The growing importance of human induced pluripotent stem cell-derived cardiomyoyctes
(hiPSC-CMs), as patient-specific and disease-specific models for studying cellular cardiac …

Human induced pluripotent stem cell‐derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block

M Paci, J Hyttinen, B Rodriguez… - British journal of …, 2015 - Wiley Online Library
Background and Purpose Two new technologies are likely to revolutionize cardiac safety
and drug development: in vitro experiments on human‐induced pluripotent stem cell …

[HTML][HTML] Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs

M Li, Y Kanda, T Ashihara, T Sasano, Y Nakai… - Journal of …, 2017 - Elsevier
Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes hold great potentials
to predict pro-arrhythmic risks in preclinical cardiac safety screening, although the hiPSC …

[HTML][HTML] Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology

CL Lei, K Wang, M Clerx, RH Johnstone… - Frontiers in …, 2017 - frontiersin.org
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) have applications
in disease modeling, cell therapy, drug screening and personalized medicine …

[HTML][HTML] Arrhythmia mechanisms in human induced pluripotent stem cell–derived cardiomyocytes

M Paci, K Penttinen, M Pekkanen-Mattila… - Journal of …, 2021 - journals.lww.com
Despite major efforts by clinicians and researchers, cardiac arrhythmia remains a leading
cause of morbidity and mortality in the world. Experimental work has relied on combining …